Clinical Research Decision-Making Assistant
Clinical Research Decision-Making Assistant
Module 1 — Lesson 1: What is Clinical Research? • Lesson 2: The Clinical Research Process
How to use this tool
- Study Classifier: Describe your project (human subjects? interventional/observational?) to classify the study type.
- Process Mapper: Indicate product status to get a recommended phase and goals.
- Ethics & Governance: Generate a checklist (IRB/IEC, informed consent, DSMB, registration, etc.).
- Outputs: Auto-build a printable plan; copy or export JSON.
- Load Scenarios: Prefill with example cases for quick learning.
Why it matters
Clinical research advances medical knowledge and patient care. Understanding fundamentals (definitions, phases, ethics) helps you choose the right design, protect participants, and meet regulatory expectations.
Study Classifier (Lesson 1)
Describe your study and get a classification + key components.
Classification & Guidance
What this means
- Interventional = You assign interventions → clinical trial protocol, safety monitoring, registration often required.
- Observational = No assigned intervention → cohort, case-control, or cross-sectional designs.
- Records/Biospecimens may be exempt/expedited in some jurisdictions but still require ethics review.
Process Mapper (Lesson 2)
Map your current status to a recommended phase and focus areas.
Recommended Step & Objectives
Phases (quick refresher)
- Phase I: Safety & dosage (often 20–80)
- Phase II: Preliminary efficacy & safety (100–300)
- Phase III: Confirmatory efficacy vs control; broader safety (hundreds–thousands)
- Phase IV: Post-market surveillance & RWE
Ethics & Governance Checklist
Generate a tailored oversight plan.
Your Governance Plan
Principles refresher
Respect for persons • Beneficence • Justice — implemented via informed consent, risk-benefit assessment, fair selection, and ongoing monitoring.
Load Example Scenarios
Use these to auto-populate fields for practice.
Diabetes drug — efficacy vs placebo
Interventional, RCT; prospective; first-in-human not done → Phase I/II path.
COVID-19 vaccine program
Interventional, randomized; sequential Phases I–III; robust Phase IV safety.
Historical — Scurvy (Lind)
Interventional, controlled diet arms; foundational trial design concepts.
Hypertension drug — Phase III
Large confirmatory RCT vs SOC; endpoints: blood pressure reduction.
Outputs
Your consolidated plan (print/copy/export).
Consolidated Plan
Lesson Summaries
Lesson 1 — What is Clinical Research?
| Topic | Content | Example |
|---|---|---|
| Definition of Clinical Research | Studies with human subjects/human-origin materials to evaluate biomedical/health outcomes. Ranges from basic science to clinical trials & epidemiology. | Trial testing a new diabetes drug for efficacy & safety in volunteers. |
| Importance | Advances knowledge, improves care, develops treatments, clarifies disease, improves diagnostics/prevention, ensures safety/efficacy. | COVID-19 vaccines built on rigorous clinical research. |
| Historical Background | Lind’s scurvy trial (1747), Nuremberg Code (1940s), Declaration of Helsinki (1964). | Lind’s grouped diet comparison pioneered trial design. |
| Key Components | Protocol, participants (consent), data collection & analysis. | Hypertension trial protocol specifies dose, duration, BP measures. |
| Ethical Considerations | Respect for persons, Beneficence, Justice. | Informed consent covering purpose, procedures, risks, benefits. |
Lesson 2 — The Clinical Research Process
Overview
| Step | Description | Example |
|---|---|---|
| Preclinical Research | Lab/cell/animal; efficacy, toxicity, PK. | New cancer drug shrinks tumors in mice; assess side effects. |
| Clinical Trials | Phases I–IV assess safety, efficacy, and real-world performance. | Phase I antiviral in 20–80 volunteers; Phase II diabetes med (100–300); Phase III hypertension drug (1,000–3,000); Phase IV long-term safety. |
| Regulatory Review & Approval | Submit comprehensive dossier (e.g., NDA/MAA). | NDA to FDA for new pain medication. |
| Post-Market Surveillance | Ongoing safety/efficacy monitoring; label updates. | New statin gets warning updates after rare AEs detected. |
Clinical Trial Phases
| Phase | Objective | Participants | Focus | Example |
|---|---|---|---|---|
| I | Safety & dosage | 20–80 | MTD, PK, side effects | Antiviral in healthy volunteers |
| II | Efficacy & side effects | 100–300 | Preliminary efficacy + safety | Diabetes med lowers HbA1c |
| III | Confirm efficacy vs standard; safety | Hundreds–thousands | Definitive endpoints | Hypertension drug vs placebo/SOC |
| IV | Post-market safety | General population | Rare AEs, long-term effects | New antidepressant RWE |
